BHVN Rega marang bathi mangsa ngarep Biohaven
High promotion costs and patent protection create significant barriers to entry for new players in neuropharmaceuticals. The forward P/E dynamics of Biohaven Ltd. demonstrate resilience, with the metric currently standing at 0.00. The efficiency of Biohaven Ltd. is based on bioinformatic automation of formula discovery, enabling the company to compete successfully with industry behemoths for priority in the registration of innovative drugs.
Rincian analitis perusahaan Biohaven Corp (BHVN)
- kuotasi lan prakiraan analis:
- data kapitalisasi pasar:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Rasio Total Utang marang Ekuitas Biohaven Ltd.|BHVN - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Biohaven Ltd.|BHVN - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Biohaven Ltd|BHVN - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Biohaven|Likuiditas cepet biohavenpharma.com
- statistik bathi lan rasio pasar:
BHVN - Bathi resik perusahaan|Bathi mangsa ngarep Biohaven Ltd.|BHVN - Rasio rega pasar marang bathi resik|Pangali Forward P/E Biohaven Pharmaceutical|BHVN - Rasio P/E diaturake wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Biohaven Ltd|BHVN - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Biohaven|BHVN - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan biohavenpharma.com|BHVN - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Biohaven Ltd.
Analisis kabeh metrik perusahaan:BHVN Biohaven
Forward P/E determines the investment payback period based on expected earnings. By analyzing the forward P/E history of Biohaven Ltd. (BHVN), an investor can track the dynamics of risk valuation. This metric correlates the current share price with the projected earnings per share. A declining multiple may signal asset degradation. For Biohaven Ltd. (BHVN), this calculation is critical, as the lack of stable revenue and dependence on clinical trials render forecasts volatile.
Karo sapa Biohaven Ltd. saingan
Pangali Forward P/E BIIB|Kapitalisasi marang proyeksi bathi Neurocrine|Rega marang bathi mangsa ngarep Regencell RGC|Axsome Corp (AXSM) - Rasio prakiraan rega marang bathi|ACADIA Pharmaceuticals - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi XENE (xenon-pharma.com)|VKTX: Pangali Forward P/E|Supernus Pharmaceuticals, Inc. (SUPN) - Pangali Forward P/E|Prakiraan rega marang bathi CPRX|Rega marang bathi mangsa ngarep DNLI|Pangali Forward P/E HRMY|AMLX - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Trevi Therapeutics, Inc. TRVI|PRAX: Rasio rega marang bathi mangsa ngarep|AVXL: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CBLL (CeriBell EEG)|prothena.com (PRTA) - Rega marang bathi mangsa ngarep|ALEC (Alector) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi ANNX|OMER (Omeros Corp.) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E NGNE|AC Immune Inc - Rasio rega marang bathi mangsa ngarep|Voyager Therapeutics - Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi neumoratx.com (NMRA)|Scilex - Pangali Forward P/E|TVGN: Rega marang bathi mangsa ngarep|ACOG: Pangali Forward P/E|Cognition Therapeutics Inc. - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi IKT|Rega marang bathi mangsa ngarep SAVA|Rega marang bathi mangsa ngarep Assertio Holdings, Inc. (ASRT)|coyatherapeutics.com - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Vistagen VTGN|OVID: Rasio rega marang bathi mangsa ngarep|Acumen Pharmaceuticals - Pangali Forward P/E|Rasio prakiraan rega marang bathi cervomed.com|ATHE (alteritytherapeutics.com) - Prakiraan rega marang bathi|Clene (CLNN) - Pangali Forward P/E|Rega marang bathi mangsa ngarep PepGen Inc|JUNS: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Relmada Therapeutics (RLMD)|ANVS - Rasio prakiraan rega marang bathi|Pangali Forward P/E GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. - Rega marang bathi mangsa ngarep|ANEW Medical, Inc. - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi NeuroSense Therapeutics NRSN|Reviva Pharmaceuticals (RVPH) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi MetaVia (MTVA)|NRXS (NeurAxis) - Pangali Forward P/E|HSDT: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E PASG|Pangali Forward P/E bionomics.com.au (NEUP)|Minerva Neurosciences - Prakiraan rega marang bathi|athira.com - Rega marang bathi mangsa ngarep|Addex Therapeutics Ltd - Pangali Forward P/E|Rasio prakiraan rega marang bathi Alzamend Neuro, Inc.|cyclerion.com (CYCN) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep PTIX|Prakiraan rega marang bathi KTTA|CRGT: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Avenue Therapeutics, Inc. (ATXI)|Rega marang bathi mangsa ngarep BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep CHRO (Chromocell)|Eliem - Pangali Forward P/E|ITCI (Intra-Cellular Therapies) - Rasio rega marang bathi mangsa ngarep|LBPH (Longboard Pharmaceuticals, Inc.) - Prakiraan rega marang bathi|MRNS - Kapitalisasi marang proyeksi bathi|NKGN (NKGen) - Pangali Forward P/E|Rega marang bathi mangsa ngarep NRBO|Pangali Forward P/E SAGE|SNPX (synaptogen.com) - Pangali mangsa ngarep rega marang bathi|Trevena - Prakiraan rega marang bathi|Vigil Neuroscience Inc. - Rega marang bathi mangsa ngarep|WENA - Rega marang bathi mangsa ngarep|CERE (Cerevel Corp) - Rasio rega marang bathi mangsa ngarep
